Best Gas Utility Companies To Buy Right Now

One-time Wall Street darling and high-flyer Rambus Inc. (NASDAQ:RMBS) is bucking an ugly, bloody tape. The memory-chip make is up more than 4% as we type thanks to an upgrade from Citi.

So you know, Rambus invents, develops, offers and licenses solutions, products and services in security, advanced LED lighting and displays, and immersive mobile media. The Company has four business units: Memory and Interfaces Division, Cryptography Research, Lighting and Display Technologies, and Mobile Technologies Division.

Analyst, Terence Whalen cites three reasons why he now sees Rambus as a "Buy" versus yesterday's "Neutral" rating. Whalen eyes a price target of $12, which is 33% upside potential to target for the tech company.

[Related -Stocks Gain Ahead Of Fed Decision; FLIR Systems, Inc. (FLIR) Jumps]

Hot Logistics Companies To Watch In Right Now: Universal Forest Products Inc (UFPI)

Universal Forest Products, Inc., incorporated on February 9, 1955, is a holding company that provides capital, management and administrative resources to c and market wood and wood-alternative products for retail building home centers and other retailers, structural lumber and other products for the manufactured housing industry, engineered wood components for the residential construction market, and specialty wood packaging and components and packing materials for various industries. Its operating segments consist of the Eastern, Western, Site-Built, Consumer Products and Distribution divisions. The Company�� subsidiaries also provide framing services for the residential market and forming products for concrete construction. The Company's consumer products operations offer a portfolio of outdoor living products, including wood composite decking, decorative balusters, post caps and plastic lattice. Its lawn and garden group offers an array of products, such as trellises and arches, to retailers nationwide. In January 2013, the Company�� subsidiary acquired Custom Caseworks, Inc.

In Retail Building Materials Market the Company offers composite wood and plastic products. The Company also sells engineered wood products to this market, which include roof trusses, wall panels and engineered floor systems. In Residential and Commercial Construction Markets, the Company supplies builders engaged in multi-family and commercial construction. It supplies wood forms and related products to set or form concrete for various structures, including garages, stadiums and bridges. The Company also provides framing services. In Manufactured Housing Market the Company distributes certain products, such as siding, electrical and plumbing to manufactured housing and RV customers. The Company define its industrial market as industrial manufacturers and agricultural customers who use pallets, specialty crates and wooden boxes for packaging, shipping and material handling purposes.

Advisors' Opinion:

• [By Marc Bastow]

  Universal Forest Products (UFPI), which provides capital and resources to the wood product industry, raised its semiannual dividend 5% to 21 cents per share, payable Dec. 15 to shareholders of record as of Dec. 1.
  UFPI Dividend Yield: 0.89%

• [By Victor Selva]

  Universal Forest Products Inc. (UFPI) is a holding company that provides capital, management and administrative resources to subsidiaries that design, manufacture and market wood and wood-alternative products. It currently consumes about 7 percent of North American softwood lumber production per year.

• [By Monica Gerson]

  Universal Forest Products (NASDAQ: UFPI) is projected to post its Q3 earnings at $0.54 per share on revenue of $625.77 million.

  Stanley Black & Decker (NYSE: SWK) is estimated to report its Q3 earnings at $1.38 per share on revenue of $2.82 billion.

Best Gas Utility Companies To Buy Right Now: Epizyme Inc (EPZM)

Epizyme, Inc., incorporated on November 1, 2007, is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. The Company systematically identify the genetic alterations that create cancer causing genes, called oncogenes, select patients in whom the identified genetic alteration is found and then design small molecule therapeutics to inhibit the oncogene. The clinical development plan for each of its product candidates is directed towards patients with a particular genetically defined cancer.The Company is conducting a Phase I clinical trial of its advanced product candidate, EPZ-5676, an inhibitor targeting the DOT1L HMT, for the treatment of mixed lineage leukemia (MLL-r). The Company has identified its two lead product candidates using its product platform.

EPZ-5676-DOT1L Inhibitor

EPZ-5676 is an intravenously administered small molecule inhibitor of DOT1L. The Company is developing EPZ-5676 for the treatment of MLL-r, an aggressive subtype of the two most common forms of acute leukemia, ALL and AML. Patients with MLL-r are routinely diagnosed with existing technologies that are commonly used in clinical setting. The Company�� Phase 1 clinical trial of EPZ-5676 is an open label, multicenter trial that has two phases.

EPZ-6438-EZH2 Inhibitor

The Company is developing EPZ-6438 as an orally available small molecule inhibitor of EZH2 for the treatment of non-Hodgkin lymphoma patients who have an oncogenic point mutation in EZH2. EZH2 is an HMT that can become oncogenic and cause non-Hodgkin lymphoma and a range of other solid tumors. Two types of non-Hodgkin lymphoma, diffuse large B-cell lymphoma of germinal-center origin, or DLBCL, and follicular lymphoma, or FL, are particularly associated with an EZH2 point mutation. There are no therapies approved specifically for the treatment of cancer associated with an EZH2 point mutation.

Advisors' Opinion:

• [By Lisa Levin]

  Epizyme (NASDAQ: EPZM) shares rose 66.84% to $34.20. The volume of Epizyme shares traded was 1683% higher than normal. Epizyme reported two major milestone achievements. It announced the achievement of a proof of concept milestone in the EPZ-5676 DOT1L inhibitor clinical program.

• [By John Udovich]

  On Tuesday, small cap biopharmaceutical company Epizyme Inc (NASDAQ: EPZM) surged 75.56% after the company announced that its�EPZ-5676, a DOT1L inhibitor for acute leukemias, had reached its proof-of-concept milestone, meaning its worth taking a closer look at the stock as well as look at the share performance of cancer stocks like large cap Celgene Corporation (NASDAQ: CELG) and small caps�Dendreon Corporation (NASDAQ: DNDN) and Geron Corporation (NASDAQ: GERN).

• [By Jake L'Ecuyer]

  Epizyme (NASDAQ: EPZM) shot up 54.63 percent to $31.70 after the company reported two major milestone achievements. It announced the achievement of a proof of concept milestone in the EPZ-5676 DOT1L inhibitor clinical program.

• [By John Udovich]
  Follow-on Stock Offerings From Small Cap Biotech Stocks. Thanks to the boom in biotech IPOs along with the sector�� overall performance, already listed biotechs have the option to ask investors for more cash in the form of a follow-on offering. Recently, FierceBiotech.com noted how four small cap biotechs raised $276 million from follow-on offerings in just one day last week. These small caps�included Epizyme Inc (NASDAQ: EPZM) which raised $88 million, Halozyme Therapeutics, Inc (NASDAQ: HALO) which raised $100 million, Agenus Inc (NASDAQ: AGEN) which raised $52 million and Idera Pharmaceuticals Inc (NASDAQ: IDRA) which raised $36 million. FierceBiotech.com noted that the�steady flow of about $4.5 billion a year in venture cash�along with�more than $3.5 billion from IPOs last year plus all of the�follow-ons are helping to foster both company growth and�accelerate drug�development programs. Mixed Bag for Biotech IPOs. Last Wednesday also saw two small cap biotech IPOs fizzle in one day�with small cap T cell vaccine developer�Genocea Biosciences Inc (NASDAQ: GNCA) raising $60 million but then ending the day down 8.3% to close at $11 while Dutch drug developer uniQure NV (QURE) raised $81.9 million but fell more than 14% to $14.61. However, orphan drug stock Auspex Pharmaceuticals Inc (NASDAQ: ASPX), which is developing�drugs to treat orphan diseases like Tourette syndrome, saw a 30.5% gain to close at $15.66 and raise $84 million. The Boston Globe quoted Michael Ringel, a partner and managing director at Boston Consulting Group who focuses on health care business, as saying:

  ��he mood is incredibly positive. Capital is flowing. [The biotech IPOs]��have been burning hot. I think it�� too early to suggest that is changing. I can�� predict the overall economy any better than anyone else, but I would expect a pretty good year for IPOs.��/p>

Best Gas Utility Companies To Buy Right Now: MedCAREERS Group Inc (MCGI)

MedCareers Group, Inc., incorporated on December 30, 2004, focus is to develop and build value through its wholly owned subsidiary Nurses Lounge (www.nurseslounge.com), an online professional network and communication source for nurses and organizations connected to the nursing community. On August 10, 2010, MedCareers acquired the workabroad.com Website from Steve Elisberg (Workabroad.com Website).

The Nurses Lounge is a professional network for nursing professionals providing relevant content and information and professional networking. Nurses can subscribe to Lounges created by nursing schools, nurse associations, employers, specialties and more to receive email updates of relevant news, events and other info. Professional networking is a place for nurses to connect with colleagues and network on a professional level.

Advisors' Opinion:

• [By Peter Graham]

  Last Friday, small cap stocks MedCAREERS Group Inc (OTCMKTS: MCGI), USmart Mobile Device Inc (OTCMKTS: UMDI) and Drinks Americas Holdings, Ltd (OTCMKTS: DKAM) were all over the place with the first two sinking 54% and 48.05%, respectively, while the last one rose 10.81%. It should be mentioned that all three small cap stocks have been the subject of paid promotions albeit none of these stocks have been over promoted. So where can investors and traders expect these stocks to head this week? Here is a quick look at what you might expect:

  MedCAREERS Group Inc (OTCMKTS: MCGI) Gets Additional Commitments to Join Its Subsidiary

  Small cap MedCAREERS Group aims to develop and build value through its wholly-owned subsidiary Nurses Lounge, Inc., an online professional network and communication source for nurses that offers a 21st century solution to recruitment and information that cannot be accomplished on a static nursing school or association website. On Friday, MedCAREERS Group sank 54% to $0.0575 for a market cap of $3.03 million plus MCGI is up 161.4% since the start of the year and down 93.9% over the past five years according to Google Finance.

Best Gas Utility Companies To Buy Right Now: Winnebago Industries Inc.(WGO)

Winnebago Industries, Inc. manufactures and sells recreation vehicles primarily for leisure travel and outdoor recreation activities. The company offers motor homes, which are self-propelled mobile dwellings that provide living accommodations for approximately seven persons and include kitchen, dining, sleeping, and bath areas, as well as a lounge; and optional equipment accessories, such as generators, home theater systems, king-size beds, upholstery, and interior equipment. It manufactures motor homes constructed directly on medium- and heavy-duty truck chassis, which include engine and drivetrain components; and on van-type chassis onto which the motor home manufacturer constructs a living area with access to the driver's compartment under the Winnebago and Itasca brand names, as well as panel-type vans with sleeping, kitchen, and/or toilet facilities under the Era brand name. The company also produces original equipment manufacturing parts, including extruded aluminum and other component products for other manufacturers and commercial vehicles. Winnebago Industries markets its motor homes through independent dealers primarily in the United States and Canada. The company was founded in 1958 and is headquartered in Forest City, Iowa.

Advisors' Opinion:

• [By John Udovich]

  The CEO of recreation vehicle (RV) stock Winnebago Industries, Inc (NYSE: WGO) recently appeared on CNBC to say that the economy is improving for RV makers, meaning its time to take a closer look at the stock plus take a look at the performance of other small cap RV stocks like Drew Industries, Inc (NYSE: DW), Skyline Corporation (NYSEMKT: SKY) and Thor Industries, Inc (NYSE: THO).

• [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

  Among the companies with shares expected to actively trade in Thursday’s session are Citigroup Inc.(C), GameStop Corp.(GME) and Winnebago Industries Inc.(WGO)

• [By Grace L. Williams]

  Recreational vehicle maker Winnebago Industries (WGO), which makes, you know, Winnebagos, is trucking today after reporting strong revenue and increased demand in its fourth quarter.

  AP

  For the period ended Aug. 31, Winnebago reported profit of $10.6 million, or 38 cents a share, down from $40.9 million, or $1.41 a share, a year earlier, while sales rose to $214.2 million in the quarter. Analysts polled by Thomson Reuters recently predicted earnings of 28 cents a share and sales of $206 million.

  Looking at the solid quarter and optimistic forecasts, Citigroup analyst Gregory Badishkanian raised estimates after noting several positive factors at the company including the current backlogs, which more than doubled, and dealer inventories, which were up 38%. He writes:

  The company highlighted two issues that appear to be diminishing: 1) towables division was dilutive for the year, but headed in the right direction with a breakeven quarter 2) shortage in Class A Gas chassis, though the issue should be resolved by mid-winter…

  Given strong margin and retail demand trends, we��e raising our 2014 and 2015 estimates by 26 cents each. We introduce our 2016 estimate of $ 1.60.

  Shares of Winnebago have gained 4.4% to $28.47 today at 3pm. Thor Industries (THO), which also makes recreational vehicles, has ticked up 0.1% to $57.56, Drew Industries (DW) has risen 0.3% to $48.74, Arctic Cat (ACAT) has advanced 1% to $59.87 and Polaris Industries (PII) has fallen 0.3% to $132.08.

• [By David Sterman]

  I took a close look at all of the companies that appeared in the first part of this series, and there were some great companies in the mix. If price were no object, I'd be a huge fan of:

  Oceaneering (NYSE: OII), which is prospering form the ongoing trends toward undersea naval warfare and undersea oil drilling. Oceaneering is poised to grow at a sustained double-digit pace, which is something few other defense contractors can say. Cree (Nasdaq: CREE): LED lighting is a revolutionary game-changer, and Cree's heavy emphasis on R&D is leading the charge towards ever-lower prices for these low-energy light sources that also have remarkable longevity compared to regular bulbs. Still, profit margin gains may be tough in a very competitive environment.  Polaris Industries (NYSE: PII): If Winnebago's (NYSE: WGO) recreational vehicles are suitable for retirees, Polaris has become the go-to name for activity-oriented vehicles. Notably, it has a revenue base that is four times larger than Winnebago as well. If S&P wants to position for future demographic trends, then Polaris is a great choice.

  I love these companies, but I don't love their stock prices, and I'd prefer to wait for some sort of pullback before singing their praises. That said, there are two investment ideas that hold great appeal on their own. If they get added to the S&P 500, then they are also set up for a timely trade.

Best Gas Utility Companies To Buy Right Now: FCCC Inc (FCIC)

FCCC, Inc. (FCCC), incorporated on March 21, 1960, is focused on merger, acquisition, reverse merger or a business transaction opportunity with an operating business or other financial transaction. The Company has not restricted its search to any particular business, industry or geographical location.

As of March 31, 2013, the Company had no arrangements or understandings with respect to any merger, acquisition, reverse merger or business combination candidate. The Company has limited operations and is actively seeking merger, reverse merger, acquisition or business combination opportunities with an operating business or other financial transaction opportunities.

Advisors' Opinion:

• [By The Science of Hitting]

  After the financial crisis, the Financial Crisis Inquiry Commission (FCIC) was created to determine the root cause of the crisis; as part of that effort, the commission was required to make the ensuing interviews of hedge fund managers, bankers, and economists available to the public. One of the people interviewed was Warren Buffett, and as expected, he didn�� disappoint. During the interview, he was asked to discuss the difference between investment and speculation; here was his response (bold added for emphasis):